ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 4 filers reported holding ENCOMPASS HEALTH CORP in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $733,790 | -38.4% | 10,926 | -37.9% | 0.00% | -40.0% |
| Q2 2023 | $1,191,696 | +4.2% | 17,600 | -8.0% | 0.01% | -16.7% |
| Q4 2022 | $1,143,926 | +69.7% | 19,126 | +85.1% | 0.01% | -14.3% |
| Q4 2021 | $674,000 | -12.0% | 10,333 | +1.2% | 0.01% | -30.0% |
| Q3 2021 | $766,000 | -6.1% | 10,207 | -2.4% | 0.01% | -16.7% |
| Q2 2021 | $816,000 | -5.9% | 10,459 | -1.2% | 0.01% | -20.0% |
| Q1 2021 | $867,000 | -5.5% | 10,583 | -4.5% | 0.02% | -11.8% |
| Q4 2020 | $917,000 | -41.2% | 11,087 | -53.8% | 0.02% | -48.5% |
| Q3 2020 | $1,559,000 | -33.6% | 23,993 | -29.2% | 0.03% | -68.9% |
| Q4 2019 | $2,348,000 | +0.9% | 33,892 | -7.9% | 0.11% | +103.8% |
| Q3 2019 | $2,328,000 | -7.3% | 36,790 | -7.2% | 0.05% | -14.8% |
| Q2 2019 | $2,512,000 | -4.3% | 39,654 | +17.7% | 0.06% | -38.4% |
| Q3 2018 | $2,626,000 | +24.0% | 33,687 | +7.8% | 0.10% | +3.1% |
| Q2 2018 | $2,117,000 | +38.6% | 31,260 | +17.0% | 0.10% | +14.3% |
| Q1 2018 | $1,527,000 | – | 26,708 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Copeland Capital Management, LLC | 569,048 | $28,117,000 | 1.78% |
| Kalos Management, Inc. | 76,118 | $3,761,000 | 1.77% |
| Bridge City Capital, LLC | 30,231 | $1,494,000 | 1.08% |
| DALTON GREINER HARTMAN MAHER & CO | 331,823 | $16,395,000 | 0.86% |
| Horrell Capital Management, Inc. | 28,641 | $1,415,000 | 0.74% |
| Polianta Ltd | 26,600 | $1,314,000 | 0.43% |
| GLOBEFLEX CAPITAL L P | 30,177 | $1,491,000 | 0.42% |
| CARILLON TOWER ADVISERS, INC. | 768,748 | $37,984,000 | 0.40% |
| EAGLE ASSET MANAGEMENT INC | 1,070,271 | $53,001,000 | 0.29% |
| S. R. Schill & Associates | 8,108 | $401,000 | 0.25% |